A B S T R A C T Endotoxin has been shown to induce amyloidosis in mice and to result in the appearance in serum of large amounts of amyloidrelated protein (SAA). After injection of 300 j.g lipopolysaccharide Escherichia coli, SAA behaves as an acute phase reactant with levels reaching a peak of >600 Ag/ml at 18-22 h and returning to base line (<50 ,ug/ml) by 48 h in each of four strains tested; only the endotoxin-resistant C3H/HeJ strain showed a smaller response. Lesser, though significant, elevations were also found after subcutaneous injection of 25 mg of casein, bovine serum albumin, ovalbumin, or monomeric immunoglobulin G, whereas pyrogen-free human serum albumin/U. S. Pharmacopeia failed to raise SAA levels. SAA generation may thus be a result of endotoxin contamination of these protein preparations.
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Also present in equivalent amounts in acidified serum from endotoxin-treated mice, but barely detectable in control sera, was a 3,000-dalton molecule whose amino acid sequence is identical to the amino terminal 24 residues of mouse albumin. The appearance of SAA and the atnino terminal albumin fragment after endotoxin were unaffected by pretreatment with cobra venom factor, and equivalent levels were found in CS-deficient mice. Pretreatment with pepstatin in vivo, or before acidification in vitro, prevented the appearance of the albumin fragment but had no effect on the appearance of SAA, whereas leupeptin and antipain did not affect the appearance of either SAA or the albumin fragment. These studies suggest that the generation of SAA after endotoxin administration does not involve complement activation or intravascular proteolytic activity, whereas the liberation of a specific peptic-like cleavage product of albumin appears to be the consequence of an acid protease.
INTRODUCTION
Bacterial endotoxins are known to possess a variety of biological effects in vivo (1) . Some of these, such as activation ofthe complement and coagulation cascades, represent, in part, direct effects of lipopolysaccharides (LPS)l on target cells (leukocytes, platelets, macrophages), possibly via adsorption to membrane receptors (2) (3) (4) , whereas other hemodynamic -and metabolic consequences of endotoxemia are presumed to be largely mediated by subsequent increased blood levels of proteolytic enzymes or vasoactive substances of lysosomal and extralysosomal origin (5) (6) (7) .
Previous work in mice and mink has shown that single subcutaneous (SC) injections of Escherichia coli LPS causes > 100-fold increases in the level ofamyloidrelated serum component (SAA) during the 24-h period after injection (8, 9) . Human volunteers given etiocholanolone show a similar dramatic rise and comparable kinetics (10) . In the course of studies designed to isolate and characterize murine SAA (11), we noted the appearance of a novel 3,000-dalton molecule in equivalent amounts in acidified endotoxemic mouse serum and identified it as the amino terminal 24 residue fragment of mouse albumin (12 6 h, 1 N NaOH was added in amounts sufficient to achieve pH 7.0 before application of Sephadex G-100 buffered with pH 7, phosphate-buffered saline (PBS). Both SAA and the low molecular weight albumin fragment were further purified by recycling on Sephadex G-75 (83 x 4.5 cm; flow rate, 13.8 mlIh) in 10% formic acid (13) .
Isolation of albumin before and after cleavage in acidified endotoxemic serum. Albumin was isolated by starch zone electrophoresis (14) from normal mouse serum or the albumin fraction obtained from endotoxemic mouse serum after fractionation on Sephadex G-100 in 10% formic acid (peak 2, Fig. 1 ).
Molecular weights. Molecular weights and purity of protein samples were determined by sodium dodecyl sulfate polyacrylamide gradient gel electrophoresis (15) . Standards included OVA (45,000 mol wt), light chain (22,500 mol wt), ribonuclease A (13,700 mol wt), and glucagon (3,485 mol wt).
Amino acid analyses. These were performed on a Durrum D-500 automatic amino acid analyzer (Durrum Instrument Corp., Palo Alto, Calif.). Proteins were hydrolyzed under vacuum at 110°C for 20 h in 6 N HCI containing 0.1% phenol to prevent destruction of tyrosine (16) .
Carboxy terminal amino acids. Carboxy terminal amino acids were determined by ½/ h and overnight digestions with Carboxypeptidase A (Worthington Biochemical Corp., Freehold, N. J.) (17) . Amino acid sequence. Determinations were performed by the method of Edman and Begg (18) with a Beckman model 890C sequencer (Beckman Instruments, Fullerton, Calif.) as previously described by using the accelerated dimethylallylamine-trifluoroacetic acid buffer program (19) . Each recovered amino acid was identified by gas and thin layer chromatography and by back hydrolysis with hydriodic acid (20, 21 Decomplementation. Mice were decomplemented by four intraperitoneal injections of cobra venom factor (CVF) (Cordis Laboratories, Miami, Fla.) given 12 h apart (first dose, 3 U/ mouse; subsequent doses, 1 U/mouse) (22) . Endotoxin was administered immediately after the last injection. Radial immunodiffusion against antimouse C3 (kindly supplied by Dr. Victor Nussenzweig, New York University Medical Center), showed levels to be <10% normal at the time of sacrifice.
Enzyme inhibitors. Enzyme inhibitors were kindly provided by Dr. Walter Troll, Department of Environmental Medicine, New York University School of Medicine. In vivo, the sodium salt of pepstatin was dissolved in water to a concentration of 1 mg/ml. Each animal received 50 gl i.p. and 0.4 ml SC 4 h before receiving endotoxin. Antipain and leupeptin were administered by a modification of a protocol developed by Dr. Mortimer Levitz, New York University School of Medicine. Each animal received 5 mg leupeptin and 6 mg antipain total in two divided doses in saline SC (0.2 ml/injection) given 16 and 4 h before receiving endotoxin. In vitro, 1 mg sodium pepstatin or 1 mg each of antipain and leupeptin was dissolved in 1 ml distilled water and added to 8 ml serum from endotoxemic mice after dialysis against water. The mixture was incubated ½2 h at 37°C and then made up to 10% formic acid before gel filtration on a Sephadex G-100 column as described above.
Antisera. Antisera to the following were raised in rabbits: (a) C57BL/6 low molecular weight SAA, isolated as described above (13); (b) C57BL/6 tissue amyloid protein (AA), derived from livers and spleens of casein-injected mice, extracted by water solubilization (23) and gel filtration (19) ; (c) C57BL/6 albumin, isolated by starch block electrophoresis (14) . In each case, rabbits were immunized with 1 mg protein in comnplete Freund's adjuvant, injected into the footpads, in divided doses, followed by three weekly booster injections of0.5 mg in complete Freund's adjuvant. Animals were bled 1-2 wk after the last booster, and antisera were tested by double diffusion.
Radioimmunoassay (RIA) for SAA. RIA for SAA was carried out as previously described (24) , using chloramine T and sodium metabisulfite for iodination (25) and precipitation of antigen-antibody complexes with polyethylene glycol (PEG) (26) . In this study, a monospecific antiserum to C57BL/6 low molecular weight SAA showing partial identity to tissue AA in double diffusion was used. Unlike antihuman SAA (27) , this antiserum was not inhibited by albumin. A highly purified preparation of C57BIJ6 low molecular weight SAA (0.5 mg/ml), previously shown to be homogeneous by polyacrylamide gel electrophoresis (15) and amino acid sequence analysis (11) was used for iodination and the preparation ofstandard curves. 100 p.l of specific rabbit antiserum, diluted 1:2,000 (50% maximal binding) was added to 50 ,l of unknown serum (diluted 1:100 and 1:500, each run in triplicate) and incubated 30 min at 37°C, followed by 50 
RESULTS
Identification and isolation of SAA and the aminoterminal fragment of albumin. As seen in Fig. 1 , when fractionated on Sephadex G-100 columns in 10% formic acid, the elution pattern of pooled dialyzed serum from endotoxin-injected animals differed strikingly from that of control, uninjected mice. The serum of animals receiving 300 ,ug E. coli LPS 18-20 h before sacrifice was characterized by the appearance of two retarded peaks (A and B), both of which were not present in significant amounts in serum of control animals. Initially both retarded peaks were separately purified on Sephadex G-75 to remove minor contaminants before sequencing; in later experiments, this proved necessary only for peak A. Both peaks were homogeneous and had molecular weights of 12,000 and 3,000 daltons determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (Fig. 2) . Calculated yields were up to 1 mg/ml serum for each (mean, 615 ,ug/ml). Similar elution patterns were obtained on groups of C57BL/6, AKR, BALB/c, and CF1 mice receiving 300 ,ug E. coli LPS. Though some variation in the height of the retarded peaks was noted between runs, the size ofpeak A was consistently less for C3H/HeJ sera than for other strains studied. Serial studies on sera diluted to 10% formic acid and stored for 1-3 d at 23°C before gel filtration showed peak A to be particularly labile and to disappear with time under acid conditions, whereas peak B seemed to increase (Fig. 3) . No change was noted in the elution profile of serum predialyzed against water for up to 5 d before acidification and gel filtration. (Fig. 1) .
Peak A was identified as SAA, because the amino acid sequence to residue 10 was virtually identical to that of AA for each of the four strains of mice (11) and because each preparation gave a reaction of identity with SAA by double diffusion using a monospecific antisera.
The presence of small amounts of A and B in control serum similarly fractionated was shown by reacting a fraction with the same elution volume as peak A with anti-SAA and by noting a very small increase in OD 280 at the position of peak B. No SAA or AA immunoreactivity by RIA could be detected in the higher molecular weight peaks 1 and 2 ( Fig. 1) .
Peak B was identified as the amino terminal 24 residues of mouse serum albumin on the basis of amino acid analysis (Table I) and complete amino acid sequence determination to residue 24 (Fig. 4) . Digestion with carboxy-peptidase A yielded Val-Leu thus establishing the sequence as complete. Mouse albumin was isolated by starch zone electrophoresis from control serum and from peak 2 (Fig. 1) of acidified serum from mice injected with LPS. Material isolated from both sources gave a reaction of identity with an antiserum to mouse albumin in double diffusion and appeared homogeneous and identical by cellulose acetate and gradient gel electrophoresis (Fig. 2) . Peak B failed to react with the antiserum (Fig. 1 ) and failed to elicit an antibody response in two rabbits.
Albumin from control serum had an amino-terminal sequence identical to that of peak B (Fig. 4) and had an amino acid composition similar to human and rat albumin (Table I) . Albumin isolated from peak 2 of LPStreated mouse serum yielded a major sequence beginning with isoleucine, which was homologous to the sequence of human and bovine albumin starting at position 25 (28, 29) (Fig. 4) . Because no sequence corresponding to that of intact albumin was detected, all albumin in this sample of acidified endotoxemic mouse serum was cleaved at leucine-isoleucine to release the amino terminal 24 residue fragment.
Role of acid pH in the generation of the albumin fragment. Sera from both control and LPS-injected FIGURE 4 Amino terminal sequences ofhuman (27) , bovine (28) , and C57BL/6 mouse (this study) albumins (ALB). These are compared to the amino terminal sequence of albumin isolated from acidified endotoxemic mouse serum by starch zone electrophoresis (mouse I) and Peak B (mouse II). 4 denotes the presumed point of cleavage by acid protease generated during endotoxemia. FIGuRE 5 Gel filtration on Sephadex G-100 toxemic serum dialyzed overnight against dist either (a) applied to a neutral (PBS) column to an acid (10% formic acid) column (0), or in 10% formic acid, neutralized with NaOH, a neutral column (A). When peaks 1 and 2 of (I lyophilized, and reapplied to an acid column, file of (b) was obtained.
mice, predialyzed to remove molecular sp daltons, were fractionated on Sephadex neutral conditions. The elution profiles si yielded the two high molecular weight I the acid columns; however, peaks A an apparent (Table II) . When these high mol peaks from the neutral column were pooled, dialyzed, lyophilized, and reapplied to Sephadex G-100 in 10% formic acid, the two retarded peaks corresponding to low molecular weight SAA and the albumin fragment were again seen (Fig. 5) . To be certain that the albumin fragment once formed did not remain complexed to another protein, we examined the role of acid in releasing the albumin fragment. Serum from LPS-injected mice was dialyzed, and then acidified and allowed to stand at room temperature for 6 h; aliquots AIN were then applied to an acid column or neutralized with NaOH and run under neutral conditions. Although low molecular weight SAA (peak A) was not seen in the elution profile of the neutral column, the size ofpeak B was similar on the neutral and the acid column (Fig. 5) .
60 70 Induction with other agents. Increase in serum SAA level and the appearance ofthe albumin fragment were of 4.5 ml endo-examined by RIA and gel filtration after injection of tilled water and OVA, BSA, monomeric IgG, casein, and HSAIUSP.
(0) (b) applied After a single injection, all agents except HSAIUSP (c) acidified 6 h caused significant elevations of SAA and the generation and applied to of the albumin fragment, the former effect peaking at a) were pooled, the elution pro-18-24 h and returning to base line by 48 h. Peak SAA levels after LPS injection for C57BL/6N, AKR, BALB/c, and CF1 strains were comparable and averaged 615 oecies <12,000 ,g/ml, whereas those for C3H/HeJ were 196 ug/ml. :G-100 under These findings are in substantial agreement with data hown in Fig. 5 (Table II) .
DISCUSSION
Injection of a single dose of endotoxin ha to cause striking elevations in the levels a and mice (8, 9) and to lead to the depositi fibrils in tissues (9, 31) . Endotoxin cd further interest in that the rise in S accompanied by the appearance of a s cleavage product of mouse albumin in a toxemic serum. After the injection of a E LPS E. coli, there is a rise in SAA levels fr( to milligram amounts, peaking with returning to base line by 48 h (8, 30) . The the SAA response appears to be influ4 nature and the amount of the inducing st as well as by genetic factors (8, 32, 33) ; peak SAA levels in the endotoxin resistant C3H/HeJ strain mice are less than one-third those obtained in other strains tested (8 (27, 38 (43) (44) (45) and may explain why albumin is cleaved exclusively at residue 24 under these conditions. Lack of other proteolytic fragments of albumin in acidified serum is suggested by the almost identical iS been shown molecular weights of control and endotoxemic mouse )fSAA in mink albumin, and the absence of intact albumin or other ion of amyloid albumin fragments in acidified endotoxemic serum. iallenge is of Thus digestion of albumin at a single site previiAA levels is ously shown to be susceptible to pepsin was demonpecific peptic strated (39) . cidified endo-A specific role for an enzyme with pepsin-like acsingle dose of tivity is suggested by the cleavage point, Leu-Ileu, om microgram the pH requirement, and the ability of pepstatin prein 24 h and treatment in vivo and in vitro to block its generation. magnitude of The efficacy ofpepstatin in vivo was first demonstrated enced by the by Aoyagi et al. (46) and is confirmed in the present timulus (8, 30) study. Pepstatin is an acid protease inhibitor of broad Serum Amyloid-Related Protein and Albumin in Endotoxemia specificity with no activity for neutral or alkaline proteases; leupeptin and antipain inhibit trypsin, cathepsins A and B, plasmin and papain (47) . In contrast, pepstatin has no effect on the release of low molecular weight SAA, and pretreatment with leupeptin and antipain was without effect on either process. The fact that acidification of normal mouse serum resulted in the expected release of SAA, but failed to yield an albumin fragment, makes cleavage by acid highly improbable. In addition, the finding that neutralization after acidification of endotoxemic serum had no effect on the appearance of peak B makes it unlikely that the role of acid pH is to dissociate the low molecular weight albumin fragment from a complex after proteolysis. However, the close association ofcertain acid proteases (e.g., cathepsins D and E) with lysosomes suggests the possibility of some function in the local pericellular inflammatory environment (48) . Because no albumin fragment could be identified at neutral pH, it seems unlikely that digestion occurs under physiological conditions.
Although both the acute rise in SAA level and the appearance of acid protease activity directed against the amino terminal end of mouse albumin result from endotoxemia, a possible relationship between the two remains speculative. Interest in the effect of decomplementation resulted from consideration of whether either effect might relate to coagulopathy and(or) complement consumption secondary to the endotoxemic state (2, 3) . However, generation of the albumin fragment was similar to normals in congenitally (C5) deficient mice or in mice made hypocomplementemic by prior administration of CVF. Previous work has established amino and carboxy terminal heterogeneity of SAA, suggesting that it may originate by proteolysis ofa larger precursor. Similarly, the conversion of SAA probably also involves proteolytic cleavage of a carboxy terminal segment (3). Because limited digestion by pepsin, trypsin, or lysosomal hydrolases can convert certain light chains in vitro to material with the tinctorial and ultrastructural properties of amyloid fibrils (49-51), it seems possible that proteolysis may play a role in the generation of several types of amyloid, perhaps by converting a soluble precursor into a fibrillar fragment. Recent work in man has suggested that the development of amyloid may relate to individual, possibly genetic, differences in the degradation of SAA to AA by specific monocyte-associated proteolytic enzymes (52) . Such work emphasizes the importance of local tissue factors in the pathogenesis of this disease, and studies are currently in progress to define the physiological controls of these phenomena.
